Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03731234
Title Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fondazione Italiana Linfomi - ETS
Indications
Therapies
Age Groups: adult
Covered Countries ITA


No variant requirements are available.